Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients

被引:1
|
作者
Sokmen, Dogukan [1 ]
Comez, Yusuf Ilker [2 ]
机构
[1] Androexpertise Clin, Istanbul, Turkiye
[2] Mem Bahcelievler Hosp, Dept Urol, Istanbul, Turkiye
来源
AGING MALE | 2023年 / 26卷 / 01期
关键词
Chronic prostatitis; chronic pelvic pain syndrome; Li-ESWT; treatment session; erectile function; SYMPTOM INDEX; INTERNATIONAL INDEX; TRIPLE-THERAPY; STIMULATION; ASSOCIATION; VALIDATION; EFFICIENCY;
D O I
10.1080/13685538.2023.2253876
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aims to evaluate the long-term effectiveness of Li-ESWT in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients and to compare the effect of treatment protocol differences on success. Method: Between December 2019 and January 2021, the data of male patients over the age of 18 who applied to the urology outpatient clinic with CP/CPPS symptoms were retrospectively analyzed. International Prostate Symptom Index (IPSS) and International Index of Erectile Function-Erectile Function (IIEF-EF) questionnaires were filled in for the evaluation of erectile function. All patients received treatment with the Medispect Bold Li-ESWT. The treatment responses of the patients who received a total of 6 sessions from one session per week and 12 sessions from two sessions per week were compared. Results: A total of 129 patients were included in the study. Significant improvements were observed in the NIH-CPSI, IPSS, and IIEF-EF scores at the third month follow-ups of the patients after EWST (p < 0.001 for each). Improvements in scores were also found to be significant in NIH-CPSI, IPSS, and IIEF-EF at the 12th month evaluation. When the patients were evaluated according to the number of Li-ESWT sessions they received, the IPSS score average of the patient group who received 12 sessions of Li-ESWT was found to be lower than the patients who received 6 sessions of Li-ESWT (5.67 +/- 2, 30 vs 4.51 +/- 2.21; p = 0.005). There was no significant difference in the IIEF-EF and IPSS scores in the 12th month evaluations of the patients, but the mean NIH-CPSI score was found to be higher in the group that received 12 sessions of LiESWT (p = 0.003). Conclusion: Li-ESWT in the treatment of CP/CPPS patients shows positive improvements in urinary symptoms, erectile function, and quality of life in patients unresponsive to other medical treatments. The increase in the number of sessions does not seem to influence the symptoms of the patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] CHRONIC PELVIC PAIN SYNDROME (CPPS) TREATMENT BY EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT) 6 MONTHS FOLLOW UP RESULTS OF 60 PATIENTS IN A RANDOMISED PLACEBO-CONTROLLED DOUBLE BLIND STUDY
    Zimmermann, Reinhold
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 255 - 255
  • [22] LONG TERM EFFICACY OF CERNILTON IN PATIENTS WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME TYPE NIH IIIA
    Wagenlehner, F. M. E.
    Schneider, H.
    Ludwig, M.
    Horstmann, A.
    Schnitker, J.
    Weidner, W.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 260 - 260
  • [23] Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
    Magri, V.
    Wagenlehner, F. M. E.
    Marras, E.
    Van Till, J. W. O.
    Houbiers, J.
    Panagopoulos, P.
    Petrikkos, G. L.
    Perletti, G.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (02) : 503 - 508
  • [24] COMPARISON OF SYMPTOMS IN NEWLY-DIAGNOSED VS CHRONIC-REFRACTORY PATIENTS WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME (CP/CPPS)
    Nickel, J. Curtis
    Alexander, Richard B.
    Anderson, Rodney U.
    Berger, Richard
    Duncan, William L.
    Krieger, John N.
    Litwin, Mark S.
    McNaughton-Collins, Mary
    Pontari, Michel A.
    Schaeffer, Anthony J.
    Shoskes, Daniel A.
    Landis, J. Richard
    Kusek, John W.
    Nyberg, Leroy M.
    Chuai, Shannon
    JOURNAL OF UROLOGY, 2009, 181 (04): : 122 - 122
  • [25] ONE YEAR FOLLOW UP OF EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT) FOR CHRONIC PELVIC PAIN SYNDROME (CPPS) IN A RANDOMISED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY
    Zimmermann, R. P.
    Cumpanas, A.
    Janetschek, G.
    JOURNAL OF ENDOUROLOGY, 2010, 24 : A272 - A272
  • [26] Short and long-term effectiveness of external shock wave therapy for chronic pelvic pain syndrome in men
    Khalafalla, Kareim
    Albakr, Ahmed
    El Ansari, Walid
    Majzoub, Ahmad
    Elbardisi, Haitham
    AlRumaihi, Khalid
    Arafa, Mohamed
    ARAB JOURNAL OF UROLOGY, 2023, 21 (03) : 162 - 169
  • [27] ONE YEAR FOLLOW UP OF EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT) FOR CHRONIC PELVIC PAIN SYNDROME (CPPS) IN A RANDOMISED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY
    Zimmerman, R. P.
    Cumpanas, A.
    Miclea, F.
    Janetschek, G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 214 - 214
  • [28] Is Serenoa repens effective for the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)? A systematic review and meta-analysis
    Lok, Waichan
    Lin, Tianhai
    Cao, Dehong
    Wei, Qiang
    ASIAN JOURNAL OF SURGERY, 2022, 45 (09) : 1746 - 1747
  • [29] Efficacy of Radial Extracorporeal Shock Wave Therapy for Chronic Pelvic Pain Syndrome: A Nonrandomized Controlled Trial
    Zhang, Zhao-Xuan
    Zhang, Dai
    Yu, Xiao-Tong
    Ma, Yue-Wen
    AMERICAN JOURNAL OF MENS HEALTH, 2018, 13 (01) : 1 - 6
  • [30] The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis
    Xiangbin Kong
    Weiwei Hu
    Zhilong Dong
    Junqiang Tian
    Yuhan Wang
    Chen Jin
    Chaozhao Liang
    Zongyao Hao
    Zhiping Wang
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 483 - 494